CODA Biotherapeutic's Series A Round

CODA Biotherapeutic raised a round of funding on September 13, 2018.

CODA Biotherapeutic is a preclinical-stage biopharmaceutical company developing a chemogenetic gene therapy platform for the treatment of intractable diseases…

Articles about CODA Biotherapeutic's Series A Round: